FTSE 100 Index & Pascal Soriot
2 shared events · Importance 3 · Last updated Aug 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
FTSE 100 Index: The FTSE 100 Index could be negatively impacted if AstraZeneca, a major constituent, shifts its listing or underperforms due to the deal uncertainty.
Pascal Soriot: Pascal Soriot, CEO of AstraZeneca, is the driving force behind the company's US pivot and the merger talks. His leadership has quadrupled AstraZeneca's share price, but the deal could face shareholder scrutiny.
Aug 02, 2026 · 60 articles
Business
FTSE 100 Index: The FTSE 100 Index was led into the red by AstraZeneca's decline following the trial failure.
Pascal Soriot: Pascal Soriot is the CEO of AstraZeneca who made optimistic statements about the trial on the Q2 2025 earnings call. The trial failure may affect his credibility and compensation.
Jul 09, 2026 · 46 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how FTSE 100 Index and Pascal Soriot interact across events, view sentiment trends, and discover connected entities.
Open Dashboard